65 related articles for article (PubMed ID: 16949153)
1. Four novel point mutations in exons 12, 13, and 14 of the FLT3 gene.
Syampurnawati M; Tatsumi E; Furuta K; Hayashi Y
Leuk Res; 2007 Jun; 31(6):877. PubMed ID: 16949153
[No Abstract] [Full Text] [Related]
2. A novel point mutation within the juxtamembrane domain of the flt3 gene in acute myeloid leukemia.
Gianfelici V; Diverio D; Breccia M; Buffolino S; Derme V; Di Lascio A; Marinelli M; Santangelo S; Meloni G; Foà R
Ann Hematol; 2011 Jul; 90(7):845-6. PubMed ID: 20924583
[No Abstract] [Full Text] [Related]
3. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S
Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862
[TBL] [Abstract][Full Text] [Related]
4. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.
Sritana N; Auewarakul CU
Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345
[TBL] [Abstract][Full Text] [Related]
5. Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML).
Ravandi F; Jilani I; Estey E; Kantarjian H; Dey A; Aguilar C; Jitkaroon C; Giles F; O'Brien S; Keating M; Albitar M
Leuk Res; 2007 Jun; 31(6):791-7. PubMed ID: 17156841
[TBL] [Abstract][Full Text] [Related]
6. FLT3 mutations in a 10 year consecutive series of 177 childhood acute leukemias and their impact on global gene expression patterns.
Andersson A; Paulsson K; Lilljebjörn H; Lassen C; Strömbeck B; Heldrup J; Behrendtz M; Johansson B; Fioretos T
Genes Chromosomes Cancer; 2008 Jan; 47(1):64-70. PubMed ID: 17943971
[TBL] [Abstract][Full Text] [Related]
7. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia.
Pinheiro RF; de Sá Moreira E; Silva MR; Alberto FL; Chauffaille Mde L
Cancer Genet Cytogenet; 2008 Jun; 183(2):89-93. PubMed ID: 18503825
[TBL] [Abstract][Full Text] [Related]
8. Investigational drugs targeting FLT3 for leukemia.
Ustun C; DeRemer DL; Jillella AP; Bhalla KN
Expert Opin Investig Drugs; 2009 Oct; 18(10):1445-56. PubMed ID: 19671038
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance and detection of the internal tandem duplication of the FLT3 gene in acute myeloid leukemia.
Gagyi E; Horváth E; Bödör C; Timár B; Matolcsy A; Pávai Z
Rom J Morphol Embryol; 2006; 47(4):331-7. PubMed ID: 17392978
[TBL] [Abstract][Full Text] [Related]
10. Images in clinical medicine. FLT3 Mutation and acute myelogenous leukemia with leukostasis.
Thornton KA; Levis M
N Engl J Med; 2007 Oct; 357(16):1639. PubMed ID: 17942876
[No Abstract] [Full Text] [Related]
11. FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype.
Ferrara F; Criscuolo C; Riccardi C; Izzo T; Pedata M; Copia C; Vicari L; Tarsitano M; Palmieri S; Pane F
Am J Hematol; 2009 Aug; 84(8):532-5. PubMed ID: 19562748
[No Abstract] [Full Text] [Related]
12. Molecular variability of FLT3/ITD mutants and their impact on the differentiation program of 32D cells: implications for the biological properties of AML blasts.
Pekova S; Ivanek R; Dvorak M; Rueggeberg S; Leicht S; Li X; Franz T; Kozak T; Vrba J; Koza V; Karas M; Schwarz J; Cetkovsky P; Prucha M
Leuk Res; 2009 Oct; 33(10):1409-16. PubMed ID: 19181379
[TBL] [Abstract][Full Text] [Related]
13. A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics.
Huang Q; Chen W; Gaal KK; Slovak ML; Stein A; Weiss LM
Br J Haematol; 2008 Jul; 142(3):489-92. PubMed ID: 18477048
[No Abstract] [Full Text] [Related]
14. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
Scholl S; Theuer C; Scheble V; Kunert C; Heller A; Mügge LO; Fricke HJ; Höffken K; Wedding U
Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of foetal-like tyrosine kinase 3 mutation in Egyptian children with acute leukaemia.
Al-Tonbary Y; Mansour AK; Ghazy H; Elghannam DM; Abd-Elghaffar HA
Int J Lab Hematol; 2009 Jun; 31(3):320-6. PubMed ID: 18336585
[TBL] [Abstract][Full Text] [Related]
16. Complete resolution of leukemia cutis with sorafenib in an acute myeloid leukemia patient with FLT3-ITD mutation.
Lee SH; Paietta E; Racevskis J; Wiernik PH
Am J Hematol; 2009 Oct; 84(10):701-2. PubMed ID: 19714594
[No Abstract] [Full Text] [Related]
17. HLA-DR-negative AML (M1 and M2): FLT3 mutations (ITD and D835) and cell-surface antigen expression.
Syampurnawati M; Tatsumi E; Furuta K; Takenokuchi M; Nakamachi Y; Kawano S; Kumagai S; Saigo K; Matsui T; Takahashi T; Nagai K; Yabe H; Kondo S; Hayashi Y
Leuk Res; 2007 Jul; 31(7):921-9. PubMed ID: 17056111
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of CD7 in acute myeloid leukemias with FLT3-ITD.
Juncà J; Zamora L; Cabezón M; Marcè S; Nomdedéu J
Am J Clin Pathol; 2008 Oct; 130(4):644; author reply 645. PubMed ID: 18825844
[No Abstract] [Full Text] [Related]
19. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.
Rausei-Mills V; Chang KL; Gaal KK; Weiss LM; Huang Q
Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib (Nexavar) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia.
Safaian NN; Czibere A; Bruns I; Fenk R; Reinecke P; Dienst A; Haas R; Kobbe G
Leuk Res; 2009 Feb; 33(2):348-50. PubMed ID: 18573526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]